Latest Close
$1.30
News
JAGX
Jaguar Health, Inc. News
This news view pulls recent coverage and headlines tied to JAGX.
1y Change
-$79.90 (-98.40%)
Market Cap
$6,383,522.00
Sector
Healthcare
Industry
Biotechnology
Recommendation
none
Presentation at ESPGHAN 2026 Describes Additional Groundbreaking Results of Evaluation of Jaguar Health's Crofelemer as Adjunctive Oral Therapy for the Treatment of Pediatric Intestinal Failure (IF)
ACCESS Newswire • Jun 30, 2026
Read articleLife Sciences Virtual Investor Forum Presentations Now Available for On-Demand Viewing
GlobeNewswire • Jun 26, 2026
Read articleJaguar Health Announces Conversion of Series O Convertible Preferred Stock Issued as Recent One-time Stock Dividend
ACCESS Newswire • Jun 25, 2026
Read articleJaguar Health Files New Animal Drug Application For Full FDA Approval Of Canine Diarrhea Therapy
MT Newswires • Jun 23, 2026
Read articleJaguar Health Completes Submission of New Animal Drug Application for Full FDA Approval of Crofelemer for Treatment of Chemotherapy-Induced Diarrhea (CID) in Dogs
ACCESS Newswire • Jun 23, 2026
Read articleLife Sciences Virtual Investor Forum Agenda Announced for June 24th & 25th
GlobeNewswire • Jun 23, 2026
Read article